ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00994786
Recruitment Status : Recruiting
First Posted : October 14, 2009
Last Update Posted : April 10, 2018
Sponsor:
Collaborators:
Pfizer
Hamilton Health Sciences Corporation
Information provided by (Responsible Party):
McMaster University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2019
  Estimated Study Completion Date : March 2019